Your browser version may not work well with NCBI's Web applications. More information here...
1: Skeletal Radiol. 2008 Mar;37(3):251-8. Epub 2007 Dec 21.
Related Articles, Links
Click here to read
Metastatic myxoid liposarcomas: imaging and histopathologic findings.

Sheah K, Ouellette HA, Torriani M, Nielsen GP, Kattapuram S, Bredella MA.

Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, YAW 6E, Boston, MA 02114, USA.

OBJECTIVE: The objective was to describe the imaging and histopathologic characteristics of metastatic myxoid liposarcomas. MATERIALS AND METHODS: This retrospective study was approved by the institutional review board and complied with HIPAA guidelines. The study group comprised 12 patients with metastatic myxoid liposarcoma who underwent MRI, CT, or FDG-PET. The location and imaging characteristics of the metastatic lesions were recorded, and the histopathology of all metastatic lesions was reviewed. RESULTS: There were 23 histologically proven metastases in 12 patients. Based on imaging criteria, there were 41 metastases. The mean time from the diagnosis of primary tumor to the first metastasis was 4.4 years. Sixty-seven percent of patients had bone and soft tissue metastases, 33% had pulmonary metastases, 33% had liver metastases, 25% had intra-abdominal, and 16% retroperitoneal metastases. CT demonstrated well-defined lobulated masses with soft tissue attenuation in all cases, without macroscopic fat component. In cases of osseous metastases, CT showed mixed lytic and sclerotic foci, with bone destruction in advanced cases. MRI demonstrated fluid-like signal intensity with mild heterogeneous enhancement in cases of soft tissue metastases. In osseous metastases, MRI showed avid heterogeneous enhancement. FDG-PET showed no significant FDG uptake for all metastases. MRI was the most useful imaging modality for osseous and soft tissue metastases. CONCLUSION: Myxoid liposarcomas are soft tissue sarcomas, with a high prevalence of extrapulmonary metastases. The bones and soft tissues were the most common site of involvement, followed by the lungs and liver. MRI was the most sensitive modality in the detection of osseous and soft tissue metastases, and is the recommended modality for the diagnosis and follow-up of bone and soft tissue involvement.

PMID: 18097662 [PubMed - indexed for MEDLINE]